Generic inhaled steroids for asthma

Increased risk of asthma-related events (death, hospitalizations, intubations) with LABA monotherapy (without ICS). Do not initiate in rapidly or acutely deteriorating COPD or asthma. Not for use with other long-acting β 2 -agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2 -agonist for acute symptoms; monitor for increased need. Monitor for signs/symptoms of pneumonia. Immunosuppressed. Tuberculosis. Systemic infections. Ocular herpes simplex. If exposed to chickenpox or measles, consider immune globulin prophylaxis or antiviral ­treatment. Monitor for adrenal insufficiency when transferring from systemic steroids. May need supplemental systemic corticosteroids during periods of stress, a severe COPD exacerbation, or a severe asthma attack. May unmask previously suppressed allergic conditions. Reevaluate periodically. Monitor for hypercorticism and HPA axis suppression (if occurs, discontinue gradually), growth in children, intraocular pressure, glaucoma, or cataracts. Discontinue if paradoxical bronchospasm occurs; use alternative therapy. Cardiovascular disease (esp. coronary insufficiency, arrhythmias, hypertension). Eosinophilic conditions. Convulsive disorders. Thyrotoxicosis. Hyperresponsiveness to sympathomimetics. Diabetes. Ketoacidosis. Hypokalemia. Hyperglycemia. Hepatic impairment; monitor. Assess bone mineral density if risk factors exist (eg, prolonged immobilization, osteoporosis, postmenopausal, advanced age, others). Pregnancy. Nursing mothers.

In an embryofetal development study in pregnant rabbits, beclomethasone dipropionate administration during organogenesis from gestation days 7 to 16 at subcutaneous doses equal to and greater than  times the MRHDID in adults (on a mg/m 2 basis at maternal doses of  mg/kg/day and higher) produced external and skeletal malformations and embryolethal effects (increased fetal resorptions). There were no effects in fetuses of pregnant rabbits administered a subcutaneous dose  times the MRHDID in adults (on a mg/m 2 basis at a maternal dose of  mg/kg/day).

There are two different types of medications that are used to treat asthma: rescue inhalers and controller therapies. Rescue inhalers treat the immediate symptoms of asthma by relaxing the smooth muscles around the airways and can be used during an asthma attack. If you have been diagnosed with asthma, you most likely will have been given a prescription for a rescue inhaler, such as albuterol and Xopenex (levalbuterol) . A generic for Xopenex HFA, levalbuterol, is also available and is a good alternative for those sensitive to albuterol sulfate.

Generic inhaled steroids for asthma

generic inhaled steroids for asthma

Media:

generic inhaled steroids for asthmageneric inhaled steroids for asthmageneric inhaled steroids for asthmageneric inhaled steroids for asthmageneric inhaled steroids for asthma

http://buy-steroids.org